Jim Simons Chemomab Therapeutics Ltd. Transaction History

Renaissance Technologies LLC

  • $63.1 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$2.58 - $4.88 $72,136 - $136,444
-27,960 Closed
0 $0
Q1 2022

May 13, 2022
BUY
$3.53 - $7.2 $98,698 - $201,312
27,960 New
27,960 $134,000
Q2 2021

Aug 13, 2021
SELL
$16.07 - $55.0 $112,859 - $386,265
-7,023 Closed
0 $0
Q1 2021

May 13, 2021
BUY
$27.2 - $127.36 $191,025 - $894,449
7,023 New
7,023 $202,000

Others Institutions Holding CMMB

# of Institutions
17
Shares Held
4.55M
Call Options Held
0
Put Options Held
0
View Full List

About Chemomab Therapeutics Ltd.

CMMB Quotes by TradingView
  • Ticker CMMB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 11,431,700
  • Market Cap $19.2M
  • Description
  • Chemomab Therapeutics Ltd., a clinical-stage biotech company, discovers and develops therapeutics for the treatment of inflammation and fibrosis. The company's lead clinical product candidate is CM-101, a humanized monoclonal antibody that hinders the basic function of soluble chemokine CCL24 for the treatment of primary sclerosing cholangitis (...
More about CMMB
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email